Carcinoid Syndrome a group of associated symptoms that occur in a percentage of patients with carcinoid tumors. Carcinoid tumors develop from hormone producing cells of the neuroendocrine system therefore can release large quantities of hormones such as serotonin, tachykinins and vasoactive peptides that cause the carcinoid syndrome symptoms. The two most common symptoms are facial flushing and diarrhea, but other symptoms include bronchoconstriction, cardiac abnormalities, gastric cramping, peripheral odema and dermatitis.
Drugs used to treat Carcinoid Syndrome
Name | Drug Class |
---|---|
Lanreotide | Somatostatin and somatostatin analogs |
Somatuline depot | Somatostatin and somatostatin analogs |